Results: COVID-19 lockdown led to negative changes in the liver of patients with NAFLD and MetS, with weight gain and increases in glycemia, ALT and intrahepatic fat content post lockdown. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.